News
Obesity has emerged as one of the most urgent and under-recognised health crises in India, with experts warning that it now functions as a silent tsunami sweeping through the population. A study ...
A new nationwide analysis is shedding light on how states compare when it comes to a major public health challenge, and the ...
For many people, losing weight is a constant struggle. Whether it’s through diet, exercise, or medical interventions, ...
Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing mood and personality changes.
Two in three adults could be obese by 2050 World Heart Report warns - More than 800 million people are said to be living with ...
While other treatment strategies most often come into play, diet and exercise are the principal staples in the fight against weight gain and obesity. The role of proper nutrition in maintaining a ...
Metformin may reduce knee pain in overweight patients with osteoarthritis, offering a low-cost alternative to early knee ...
Weightwatchers and bariatric surgery had limited effects on the obese brain, but GLP-1s like Ozempic may mean new hope in ...
While the US leads in early-phase obesity trials and investment, the country also faces challenges in disease burden, trial ...
Estrogen generated in the brain may play a role in regulating appetite, potentially opening new avenues for treating obesity.
The $7.8 million investment will fund further drug testing and development to advance its drug candidates to clinical trials.
Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results